Background
Dr. Anton Bonci is a nationally recognized physician and neuroscientist who anchors the RECO Health network's expertise in advanced neuromodulation. With over 25 years of research and clinical innovation, he is widely known for his work on the neurobiology of addiction and on Transcranial Magnetic Stimulation (TMS) as a clinical treatment.
Dr. Bonci's career has included some of the most prominent leadership roles available in addiction research — Scientific Director at the National Institute on Drug Abuse (NIDA) and senior investigator at the NIH. He is currently Founder and Chief Scientific Officer of GIA Healthcare. His connection to RECO Health ensures the network's neuromodulation work is grounded in the most current science.
Approach to Care
Dr. Bonci's clinical philosophy is grounded in the conviction that the brain is a treatable organ. The neurobiology of addiction — the specific circuits and signaling pathways that get hijacked, and how to intervene at each — is no longer theoretical, and he is one of the people who helped make that possible. At RECO Health, his role is to make sure the most current, validated neuromodulation approaches are available to patients across the network.
Education & Credentials
Dr. Bonci earned his medical degree from the University of Sassari in Italy and completed advanced training in neuroscience and psychiatry. He has authored numerous peer-reviewed publications and is internationally recognized for translating neuroscience research into evidence-based clinical treatments.
What to Expect
Most RECO Health patients won't meet Dr. Bonci personally — but his influence is in the protocols, candidate selection criteria, and clinical standards that define the network's TMS and neuromodulation programs. Families evaluating advanced options can take his presence on the team as a meaningful signal of program rigor.
